K101181 is an FDA 510(k) clearance for the BEL-CAT. Classified as X-ray, Tomography, Computed, Dental (product code OAS), Class II - Special Controls.
Submitted by Takara Belmont Corp. (Naples, US). The FDA issued a Cleared decision on July 19, 2011 after a review of 448 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.
View all Takara Belmont Corp. devices